Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07802366
NA

Market Research of a Slow Release Protein Substitute for the Dietary Management of PKU

Sponsor: metaX Institut fuer Diatetik GmbH

View on ClinicalTrials.gov

Summary

XPhePiccosMR is a prospective, single-arm, open label, observational study that aims to evaluate the acceptability and tolerability of XPhe Piccos, a slow-release, phenylalanine-free protein substitute in the form of tiny tablets, for use in the dietary management of phenylketonuria (PKU) in children aged three years and older.

Official title: XPhe Piccos - Acceptability and Tolerance Market Research

Key Details

Gender

All

Age Range

3 Years - 18 Years

Study Type

INTERVENTIONAL

Enrollment

10

Start Date

2026-10-15

Completion Date

2027-08-01

Last Updated

2026-10-15

Healthy Volunteers

No

Interventions

DIETARY_SUPPLEMENT

Slow release, phenylalanine-free protein substitute tablets

The slow release, phenylalanine-free protein substitute in tablet form (XPhe Piccos) is a food for special medical purposes (FSMP) for use in the dietary management of Phenylketonuria or Hyperphenylalaninemia. The product is suitable from 3 years of age and over. XPhe Piccos are a highly concentrated phenylalanine-free protein supplement in the form of very small tablets/pellets enriched with vitamins, minerals and trace elements. XPhe Piccos are characterized by a prolonged release of the amino acids.

Locations (1)

Birmingham Children´s Hospital

Birmingham, England, United Kingdom